NURS6630 Final Exam: Walden University GRADED A

NURS6630 Final Exam:




NURS6630 Final Exam: Walden University


QUESTION 1


What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs to

manage the top-down cortical control and the excessive drive from striatal hyperactivity?


A. Stimulants B. Antidepressants C. Antipsychotics D. SSRIs


QUESTION 2


The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic

behaviors with poor impulse control and aggression. Of the available treatments, which can help

temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?


A. First-generation, conventional antipsychotics B. First-generation, atypical antipsychotics C.

Second-generation, conventional antipsychotics D. Second-generation, atypical antipsychotics


QUESTION 3


The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive

behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of

atypical antipsychotics?


A. The doses are based on achieving 100% D2 receptor occupancy. B. The doses are based on

achieving a minimum of 80% D2 receptor occupancy. C. The doses are based on achieving

60% D2 receptor occupancy. D. None of the above.

,NURS6630 Final Exam:




QUESTION 4


Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the

patient with psychosis and aggression?


A. There is too high a risk of serious adverse side effects. B. It can exaggerate the psychotic

symptoms. C. Clozapine (Clozaril) should not be used as high-dose monotherapy. D. There is no

documentation that clozapine (Clozaril) is effective for patients who are violent.


QUESTION 5


The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the

PMHNP exhibits proper care for this patient?


A. Explaining to the patient that there are no risks of EPS B. Prescribing the patient 12 mg/dail

C. Titrating the dose by increasing it every 5–7 days D. Writing a prescription for a higher

dose of oral risperidone (Risperdal) to achieve high D2 receptor occupancy


QUESTION 6


The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and

impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will

the PMHNP select? A. Lithium (Lithane) B. Phenytoin (Dilantin) C. Valproate (Depakote) D.

Topiramate (Topamax)

, NURS6630 Final Exam:




QUESTION 7


The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on

their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which

medication will the PMHNP will most likely prescribe?


A. Strattera B. Concerta C. Daytrana D. Adderall


QUESTION 8


8 The PMHNP understands that slow-dose extended release stimulants are most appropriate for

which patient with ADHD?


A. 8-year-old patient B. 24-year-old patient C. 55-year-old patient D. 82-year-old patient


QUESTION 9


A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the

PMHNP include when discussing the side effects with the patient?


A. The formulation can have delayed actions when taken with food. B. Sedation can be a

common side effect of the drug. C. The medication can affect your blood pressure. D. This

drug does not cause any dependency.


QUESTION 10


The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will the

PMHNP include in the teaching?